We asked 135 radiology professionals their opinions on the current job market for radiology technologists, an issue that seems to be weighing heavy on the profession, and has cultivated some pretty strong opinions about the politics involved in imaging schools and accreditation bodies. 53% of our survey participants attributed the main cause of job shortages
By: Ajay K Malik, PhD Technetium-99m (Tc-99m) is the most used radioactive tracer with over 30 million tests per year done all over the world. When tagged to a pharmaceutical or biological marker, it helps evaluate, diagnose or manage cancer spread, blood flow and cardiac function; brain activity and thyroid disease; and detect osseous metastasis,
The investigational radioisotope, F-18 FLT (fluorothymidine), is showing promise in clinical trials in the ability to assess response to cancer treatment. Research into the clinical applications of the FLT radiotracer has been underway for over 10 years. After FDA approval for use in clinical trials, the molecular imaging community is holding much promise in the
By Ajay K Malik, PhD Over the last forty years, we have made great strides in the diagnosis and treatment of cancer. According to the Centre for Disease Control and Prevention (CDC), the number of cancer survivors have steadily increased from three million in 1971 to over eleven million today; one in twenty Americans is
A recent NIH study has found PEM to have greater specificity than Breast MRI in detecting cancerous and benign lesions of the breast, and with a 26% higher Positive Predictive Value than Breast MRI, PEM could result in a reduction in unnecessary breast biopsies. This results in reduced patient trauma as well as lower costs associated with breast cancer detection and staging.
New technologies in nuclear breast imaging could mean a huge increase in accurate detection of breast cancer. Recent findings show MDI to detect 3 times as many malignancies with a higher PPV. By Maggie E. Mason